Growing community of inventors

Welwyn Garden, United Kingdom

Rene Robert Devos

Average Co-Inventor Count = 7.58

ph-index = 5

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 374

Rene Robert DevosJoseph Armstrong Martin (6 patents)Rene Robert DevosJohn Herbert Merrett (6 patents)Rene Robert DevosIsabel Najera (6 patents)Rene Robert DevosChristopher John Hobbs (6 patents)Rene Robert DevosNobuo Shimma (5 patents)Rene Robert DevosTakuo Tsukuda (5 patents)Rene Robert DevosWen Rong Jiang (4 patents)Rene Robert DevosWen-Rong Jiang (2 patents)Rene Robert DevosRene Robert Devos (6 patents)Joseph Armstrong MartinJoseph Armstrong Martin (15 patents)John Herbert MerrettJohn Herbert Merrett (10 patents)Isabel NajeraIsabel Najera (8 patents)Christopher John HobbsChristopher John Hobbs (6 patents)Nobuo ShimmaNobuo Shimma (35 patents)Takuo TsukudaTakuo Tsukuda (14 patents)Wen Rong JiangWen Rong Jiang (4 patents)Wen-Rong JiangWen-Rong Jiang (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Roche Palo Alto LLC (4 from 322 patents)

2. Hoffmann-la Roche Inc. (1 from 4,942 patents)

3. Syntex (u.s.a.) Inc. (1 from 932 patents)


6 patents:

1. 8648054 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication

2. 8071567 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication

3. 7915232 - 4'-substituted nucleoside derivatives as inhibitors of HCV RNA replication

4. 7608601 - 4'-Substituted nucleoside derivatives as inhibitors of HCV RNA replication

5. 6784166 - 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication.

6. 6660721 - Anti-HCV nucleoside derivatives

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…